A look into the OD's role in the management of MIGS

Video

Justin Schweitzer, OD, shares key highlights from his presentation titled, "The OD's Role in the Management of MIGS in 2022," where he explores earlier intervention for glaucoma patients.

Optometry Times'® Kassi Jackson talks with Justin Schweitzer, OD, optometric externship director with Vance Thompson Vision in Sioux Falls, South Dakota, and one of the associate directors of the optometric residency program at Vance Thompson Vision, about his presentation titled, "The OD's Role in the Management of MIGS in 2022," which he is presenting during this year's AOA annual meeting in Chicago.

"Optometry, in general, needs to be involved in thinking about managing patients with minimally invasive glaucoma procedures," Schweitzer said.

Though ODs aren't the ones performing MIGS procedures, he said the terminology he thinks about is "interventional glaucoma" and how to intervene earlier in the disease process of glaucoma patients.

"By the year 2030, there's going to be about 4.1 million Americans with glaucoma; and by the year 2050, there's going to be about 6.3 million Americans with glaucoma," Schweitzer said.

"And the facts are that if we don't work hand-in-hand with ophthalmology and embrace some of these procedures, and embrace the management of glaucoma, embrace the postoperative care of MIGS procedures, the only people that are likely going to suffer will be our patients." - Justin Schweitzer, OD.

Key takeaways:

  • Glaucoma is a medical disease, as well as a surgical disease; it is a marathon, not a sprint.
  • Glaucoma treatment and management is collaborative.
  • It is important to balance safety and effectiveness, and MIGS fits into that category.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
© 2025 MJH Life Sciences

All rights reserved.